Department of Oral Pathology, School of Dentistry and Dental Research Institute, Seoul National University, Seoul, Korea.
Center for Gastric Cancer, National Cancer Center, Goyang, Korea.
J Oral Pathol Med. 2017 Oct;46(9):752-758. doi: 10.1111/jop.12566. Epub 2017 Mar 28.
SOX7, a member of the SOX family of transcription factors, acts as a tumor suppressor in multiple cancers. Downregulation of SOX7 has been reported in advanced tumors and correlates with poor prognosis. The aims of this study were to investigate the effects of SOX7 on cell proliferation, invasion, and colony formation in oral squamous cell carcinoma (OSCC) cells and to evaluate the effectiveness of SOX7 protein as a prognostic indicator for OSCC patients.
oral squamous cell carcinoma (OSCC) cell lines were treated with SOX7 small interfering RNA or SOX7 peptide, and their effects on cell proliferation, invasiveness, and colony formation were investigated by proliferation, in vitro invasion, and clonogenic assays. SOX7 protein expression in OSCC and normal oral mucosal tissues was examined by immunohistochemistry. Associations between SOX7 protein expression and clinicopathological parameters of OSCC patients were statistically analyzed.
SOX7 silencing-induced cell proliferation and invasion in SCC-4 cells. SOX7 peptide treatment inhibited cell proliferation, colony formation, and invasion in SCC-9 and SCC-25 cells. Expression of SOX7 protein was decreased in OSCC tissues compared with normal oral mucosal tissues (P<.001). Negative SOX7 expression in patients with OSCC was significantly associated with positive lymph node metastasis (P=.041), advanced TNM stage (P=.024), and poor prognosis (P=.017).
These results suggest that SOX7 inhibits cell proliferation, colony formation, and invasion in OSCC as a tumor suppressor and that negative SOX7 expression could be a poor prognostic indicator for patients with OSCC.
SOX7 是 SOX 转录因子家族的成员,在多种癌症中作为肿瘤抑制因子发挥作用。已有报道称,SOX7 在晚期肿瘤中下调,并与不良预后相关。本研究旨在探讨 SOX7 对口腔鳞状细胞癌(OSCC)细胞增殖、侵袭和集落形成的影响,并评估 SOX7 蛋白作为 OSCC 患者预后指标的有效性。
用 SOX7 小干扰 RNA 或 SOX7 肽处理口腔鳞状细胞癌细胞系,通过增殖、体外侵袭和集落形成实验研究其对细胞增殖、侵袭和集落形成的影响。用免疫组织化学法检测 OSCC 和正常口腔黏膜组织中 SOX7 蛋白的表达。对 OSCC 患者 SOX7 蛋白表达与临床病理参数之间的关系进行统计学分析。
沉默 SOX7 可诱导 SCC-4 细胞增殖和侵袭。SOX7 肽处理抑制 SCC-9 和 SCC-25 细胞的增殖、集落形成和侵袭。与正常口腔黏膜组织相比,OSCC 组织中 SOX7 蛋白的表达降低(P<.001)。OSCC 患者 SOX7 阴性表达与阳性淋巴结转移(P=.041)、晚期 TNM 分期(P=.024)和不良预后(P=.017)显著相关。
这些结果表明,SOX7 作为肿瘤抑制因子抑制 OSCC 中的细胞增殖、集落形成和侵袭,SOX7 阴性表达可能是 OSCC 患者的不良预后指标。